Press release
Generic Pharmaceuticals Contract Manufacturing Market is Anticipated to Expand upto $87.59 Billion in 2029
Generic Pharmaceuticals Contract Manufacturing Market Size
What Is the Forecasted Market Growth Rate of the Generic Pharmaceuticals Contract Manufacturing Industry?
In recent years, there has been robust growth in the generic pharmaceuticals contract manufacturing market. The market size will escalate from $62.30 billion in 2024 to $66.82 billion in 2025, expanding at a compound annual growth rate (CAGR) of 7.3%. This growth in the previous years can be credited to a surge in demand for affordable medicines, increasing health care costs in emerging economies, a growth in patent expirations for branded drugs, an upswing in outsourcing from pharmaceutical corporations, and an increasing prevalence of chronic diseases.
How Will the Generic Pharmaceuticals Contract Manufacturing Market Size Evolve From 2025 to 2029?
The market for contract manufacturing in the generic pharmaceuticals sector is predicted to exhibit robust growth in the near future. By 2029 it's forecasted to escalate to $87.59 billion, with a compound annual growth rate (CAGR) of 7.0%. The projected growth during this period can be traced back to several factors, including an increasing emphasis on specialty generics, growing governmental support for the use of generic medicines, enhanced healthcare availability in emerging markets, an upsurge in investments in contract manufacturing facilities, and an escalating demand for scalable and flexible manufacturing solutions. In the coming years, major market trends will involve progress in automation in manufacturing, refined quality check technologies, the evolution of intricate generic formulations, innovation in the arena of drug delivery systems, and advancements in ongoing manufacturing processes.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-contract-manufacturing-global-market-report
What Are the Main Growth Drivers in the Generic Pharmaceuticals Contract Manufacturing Market Today?
The growth of the generic pharmaceuticals contract manufacturing sector is projected to be boosted by increasing demand for biosimilars. Biosimilars are bio-medical products that closely resemble their already sanctioned reference biologics, offering no vital disparities in safety, potency, or purity. The escalating demand stems from their capacity to serve as cost-efficient substitutes to high-priced biological drugs, thus making high-end treatments more attainable for patients and health systems. Contract manufacturing of generic pharmaceuticals aids biosimilars by supplying affordable, large-volume production capabilities and regulatory know-how required to hasten market entry and maintain consistent quality. As per Cardinal Health Inc., a healthcare entity based in the US, as of January 2022, the US FDA had approved 33 biosimilar products, with 21 available in the market. By January 2023, this number had increased to 40 approved biosimilars, with 25 commercially accessible. Hence, the elevating demand for biosimilars is stimulating the expansion of the generic pharmaceuticals contract manufacturing market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25771&type=smp
Which Generic Pharmaceuticals Contract Manufacturing Market Segment Is Expected to Lead Through 2029?
The generic pharmaceuticals contract manufacturing market covered in this report is segmented -
1) By Drug Type: Branded Generics, Unbranded Generics
2) By Product Type: Pharmaceutical Active Pharmaceutical Ingredients, Formulations, Capsules, Tablets, Injectables
3) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
4) By Application: Oncology, Immunology, Antidiabetic, Neurology, Anticoagulants, Cardiovascular, Respiratory, Pain, Human Immunodeficiency Virus Antivirals
5) By End-User Industry: Pharmaceutical Companies, Contract Research Organizations, Biotechnology Companies, Generic Drug Manufacturers
Subsegments:
1) Branded Generics: Contract Development of Branded Formulations, Branded Generic Tablet Manufacturing, Branded Injectable Manufacturing, Packaging and Labeling for Branded Generics, Regulatory Support For Branded Generics
2) By Unbranded Generics: Bulk Manufacturing of Off-Patent Active Pharmaceutical Ingredients, Generic Tablet Or Capsule Production, Parenteral Or Injectable Generic Manufacturing, Cost-Efficient Packaging for Unbranded Products, Licensing And Tech Transfer for Generic Products
Which Market Trends Are Expected to Dominate Generic Pharmaceuticals Contract Manufacturing Industry Growth?
Key players in the generic pharmaceutical contract manufacturing market are advancing their service offerings through the formation of specialized subsidiaries to cater to the increasing need for outsourced development and manufacturing. This strategic detour in setting up specific subsidiaries assists companies in enhancing the production of active pharmaceutical ingredients (APIs), ensuring adherence to regulations, scalability, and operational effectiveness throughout the medication development process. For illustration, Lupin, a generic pharmaceutical corporation based in India, unveiled its novel subsidiary, Lupin Manufacturing Solutions (LMS), in July 2025, marking its entry into the contract development and manufacturing organization (CDMO) market. This specialized division is purposed to assist in the evolution, production, and distribution of APIs for international pharmaceutical collaborators. The subsidiary, headed by a team with substantial biotech and pharma experience, is poised to provide superior contract services, aiding pharmaceutical firms in hastening their market launch time, ensuring compliance with regulatory norms, and maintaining cost-effectiveness.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25771&type=smp
Which Companies Hold the Largest Market Share in the Generic Pharmaceuticals Contract Manufacturing Sector?
Major companies operating in the generic pharmaceuticals contract manufacturing market are Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Fresenius Kabi AG, WuXi AppTec Co. Ltd., Aurobindo Pharma, Cipla Limited, Recipharm AB, Siegfried Holding AG, Curia Global Inc., Torrent Pharmaceuticals Limited., Piramal Pharma Solutions, Laurus Labs Limited., Cambrex Corp., Pfizer CentreOne, Syngene International Ltd., Wockhardt Ltd., Alcami Corp. Inc, Neuland Laboratories Limited., Panacea Biotec Ltd., Jubilant Generics Ltd.
Where Is the Generic Pharmaceuticals Contract Manufacturing Market Experiencing the Highest Growth?
North America was the largest region in the generic pharmaceuticals contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic pharmaceuticals contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Pharmaceuticals Contract Manufacturing Market is Anticipated to Expand upto $87.59 Billion in 2029 here
News-ID: 4157472 • Views: …
More Releases from The Business Research Company
Ammonium Sulfate Market on Path to Hit $5.99 Billion by 2029 at 9.6% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Ammonium Sulfate Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market size for ammonium sulfate has seen substantial growth in the past few years. The market is set to increase from a value of $3.88 billion in 2024 to $4.16 billion in 2025, with a compound annual…
Global Biodegradable Hemostat Market Expansion at 10.9% CAGR, Valued at $1.48 Bi …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Biodegradable Hemostat Market Size Forecast for 2025?
The market size for biodegradable hemostats has experienced striking growth in the past few years. From being valued at $0.88 billion in 2024, it is predicted to grow to $0.97 billion in 2025, attaining a compound annual growth rate (CAGR)…
Aerospace Interior Adhesive Market to Record 7.8% CAGR Growth Through 2029 | Glo …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Aerospace Interior Adhesive Market Outlook: How is the Market Expected to Grow by 2025?
Recent years have seen robust growth in the aerospace interior adhesive market. The market is projected to expand from $1.27 billion in 2024 to $1.34 billion in 2025, posting a compound annual growth rate (CAGR) of…
Aseptic Connectors And Welders Market Expansion Outlook: $3.96 Billion in 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Aseptic Connectors And Welders Market from 2024 to 2025?
In recent times, there has been a swift surge in the size of the aseptic connectors and welders market. The market is forecasted to escalate from $1.72 billion in 2024 to $2.04 billion in 2025, representing…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
